Addiction - Neurobiology, Prevention, and Treatment - Part 1
$9.00 | CE Hours:3.00 | Intermediate
CE Course Description
This CE course explains the neurobiological basis for substance use disorders and provides the biological, psychological, and social frameworks for improving diagnosis, prevention, and treatment of alcohol and drug misuse. Evidence-based prevention strategies, effective treatment strategies, and recovery support services are also described in this course.
Author: U.S. Department of Health and Human Services (HHS), Office of the Surgeon General, Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC: HHS, November 2016.
Center for Behavioral Health Statistics and Quality. (2016). Results from the 2015 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Rudd, R.A., Aleshire, N., Zibbel, J.E., & Gladden, R.M. (2016). Increases in drug and opioid overdose deaths - United States, 2000-2014. MMWR, 64(50), 1378-1382.
Dowell, D., Haegerich, T.M., & R., C. (2016). CDC guideline for prescribing opioids for chronic pain - United States. MMWR, 65(1), 1-49.
Retrieved from: https://www.hhs.gov/
CE Course Objectives
1. Investigate what research suggests to do to address the problem of fatal medication errors due to interactions between a prescribed medication for a diagnosed medical condition and patient substance use.
2. Scrutinize the single factor that will determine whether an individual will develop a substance misuse problem or disorder.
3. Identify when the likelihood of substance use peaks.
4. Describe where the negative feelings associated with withdrawal are thought to come from.
CE Outline with Main Points
1. Introduction and Overview
a. Prevalence of Substance Use, Misuse Problems, and Disorders
b. Costs and Impact of Substance Misuse
c. Vulnerability to Substance Misuse Problems and Disorders
d. Diagnosing a Substance Use Disorder
e. The Separation of Substance Use Treatment and General Health Care
f. Recent Changes in Health Care Policy and Law
g. Marijuana: A Changing Legal and Research Environment
2. The Neurobiology of Substance Use, Misuse, and Addiction
a. Conducting Research on the Neurobiology of Substance Use, Misuse, and Addiction
b. The Primary Brain Regions Involved in Substance Use Disorders
c. The Addiction Cycle
d. Binge / Intoxication Stage: Basal Ganglia
e. Withdrawal / Negative Affect Stage: Extended Amygdala
f. Factors that Increase Risk for Substance Use, Misuse, and Addiction
g. Use of Multiple Substances and Co-occurring Mental Health Conditions
h. Biological Factors Contributing to Population-based Differences in Substance Misuse and Substance Use Disorders
3. Prevention Programs and Policies
a. Why We Should Care About Prevention Risk and Protective Factors
b. Risk and Protective Factors
c. Types of Prevention Interventions
d. Evidence-based Prevention Programs
e. Evidence-based Community Coalition-based Prevention Models
f. Evidence-based Prevention Policies
g. Prevention Interventions for Specific Populations
h. Improving the Dissemination and Implementation of Evidence-based Programs
Date Added: 2019-06-07
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degree of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.
*Board Approvals for this course can be found here.
*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at: email@example.com.